Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
QuintilesIMS
Baxter
Merck
Cipla
Healthtrust
Teva
Dow

Generated: November 12, 2018

DrugPatentWatch Database Preview

Biologic Drugs With Dosage Form: GEL; TOPICAL

« Back to Dashboard

Details for Dosage Type: GEL; TOPICAL

Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up Ethicon, Inc. (Somerville, NJ) ➤ Sign Up RX company
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up LTS Lohamann Therapie-Systeme AG (Andernach, DE) ➤ Sign Up RX search
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up University of Louisville Research Foundation, Inc. (Louisville, KY) ➤ Sign Up RX search
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up University of Louisville Research Foundation, Inc. (Louisville, KY) ➤ Sign Up RX search
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) ➤ Sign Up RX search
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up Torrent Pharmaceuticals Limited (Ahmedabad, IN) ➤ Sign Up RX search
Omj Pharmaceuticals REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16 ➤ Sign Up Torrent Pharmaceuticals Limited (Ahmedabad, IN) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Healthtrust
Mallinckrodt
Accenture
Federal Trade Commission
Citi
Covington
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Generic Entry Opportunies 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: